Related references
Note: Only part of the references are listed.Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
Hendrik Van Poppel et al.
NATURE REVIEWS UROLOGY (2022)
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer
Yingke Zhou et al.
CANCER RESEARCH (2021)
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives
Nicole Brighi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells
Zohaib Rana et al.
PHARMACEUTICALS (2021)
AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption
Navid Sobhani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Androgens promote vascular endothelial cell proliferation through activation of a ZIP9-dependent inhibitory G protein/PI3K-Akt/Erk/cyclin D1 pathway
Aubrey Converse et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2021)
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer
Cheng Wu et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Cyclin E in normal physiology and disease states
Chen Chu et al.
TRENDS IN CELL BIOLOGY (2021)
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors
Andre Richters et al.
CELL CHEMICAL BIOLOGY (2021)
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
Per Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
Elin Ersvaer et al.
MODERN PATHOLOGY (2020)
Role of androgen receptor splice variants, their clinical relevance and treatment options
S. Wach et al.
WORLD JOURNAL OF UROLOGY (2020)
Cell cycle regulators in cancer cell metabolism
Lucia C. Leal-Esteban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
CDK7 inhibitors as anticancer drugs
Georgina P. Sava et al.
CANCER AND METASTASIS REVIEWS (2020)
Mammalian cell cycle cyclins
Diego Martinez-Alonso et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
Chen Peng et al.
CANCER CELL INTERNATIONAL (2020)
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Timothy O. Adekoya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Boris Y. Shorning et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review
Tae Jin Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Dihydrotestosterone (DHT) Enhances Wound Healing of Major Burn Injury by Accelerating Resolution of Inflammation in Mice
Huaikai Shi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Angiogenesis Inhibition in Prostate Cancer: An Update
Chandrani Sarkar et al.
CANCERS (2020)
Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma
Francesca Ida Montalto et al.
CELLS (2020)
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
Gaetano Aurilio et al.
CELLS (2020)
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer
Laura Cato et al.
CANCER CELL (2019)
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
Bowen Xie et al.
CANCER LETTERS (2019)
Mechanisms of PTEN loss in cancer: It's all about diversity
Virginia Alvarez-Garcia et al.
SEMINARS IN CANCER BIOLOGY (2019)
Targeting Angiogenesis in Prostate Cancer
Zsombor Melegh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Towards precision oncology in advanced prostate cancer
Sheng-Yu Ku et al.
NATURE REVIEWS UROLOGY (2019)
A magic drug target: Androgen receptor
Dan Li et al.
MEDICINAL RESEARCH REVIEWS (2019)
Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice
Pedro Augusto Marischka Mateus et al.
PROSTATE (2019)
Direct Targeting Options for STAT3 and STAT5 in Cancer
Anna Orlova et al.
CANCERS (2019)
Therapeutic targeting of transcriptional cyclin-dependent kinases
Matthew D. Galbraith et al.
TRANSCRIPTION-AUSTIN (2019)
Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness
Sofia Halin Bergstrom et al.
PROSTATE (2018)
Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81
Radek Jorda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway
Dawei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
Yi-Mi Wu et al.
CELL (2018)
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
Srinivas R. Viswanathan et al.
CELL (2018)
Veterinary drug, 17β-trenbolone promotes the proliferation of human prostate cancer cell line through the Akt/AR signaling pathway
Hee-Seok Lee et al.
CHEMOSPHERE (2018)
Issues and promises of bevacizumab in prostate cancer treatment
Vittore Cereda et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Development of selective androgen receptor modulators (SARMs)
Ramesh Narayanan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Interleukin-6 and prostate cancer: Current developments and unsolved questions
Zoran Culig et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
MPF-based meiotic cell cycle control: Half a century of lessons from starfish oocytes
Takeo Kishimoto
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2018)
ZIP9 but not the androgen receptor mediates testosterone-induced migratory activity of metastatic prostate cancer cells
Ahmed Bulldan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies
Joseph A. Caruso et al.
CANCER RESEARCH (2018)
Implications of prostate inflammation on male fertility
Ruben D. Motrich et al.
ANDROLOGIA (2018)
Structure and function of FUS gene in prostate cancer
E. Ghanbarpanah et al.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2018)
Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer
Guilhem Roubaud et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Rho GTPases: Anti- or pro-neoplastic targets?
I. Zandvakili et al.
ONCOGENE (2017)
Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Ronald S. Swerdloff et al.
ENDOCRINE REVIEWS (2017)
Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells
Vijayalakshmi Thamilselvan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Cell-Cycle Therapeutics Come of Age
Matthew Ingham et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue
Gang Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer
Gabriele Di Sante et al.
ONCOTARGET (2017)
Androgen receptor splice variants and prostate cancer: From bench to bedside
Kristine M. Wadosky et al.
Oncotarget (2017)
CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion
Long Fan et al.
ONCOTARGET (2017)
Non-Genomic Actions of the Androgen Receptor in Prostate Cancer
Jacky K. Leung et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Stromal Androgen Receptor in Prostate Cancer Development and Progression
Damien A. Leach et al.
CANCERS (2017)
Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells
Mathew C. Casimiro et al.
CANCER RESEARCH (2016)
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage
F. Marampon et al.
ONCOTARGET (2016)
IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2
Constanze Merz et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells
Ozge Berrak et al.
APOPTOSIS (2016)
Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow
Regina Miftakhova et al.
CANCER RESEARCH (2016)
Condensin recruitment to chromatin is inhibited by Chk2 kinase in response to DNA damage
Tao Zhang et al.
CELL CYCLE (2016)
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer
Hetal Patel et al.
CLINICAL CANCER RESEARCH (2016)
The PI3K AKT pathway in the pathogenesis of prostate cancer
Xiaofei Wen
Frontiers in Bioscience-Landmark (2016)
Androgen Control in Prostate Cancer
Vasiliki Pelekanou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Tanya Stoyanova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Noel P. Fuste et al.
ONCOTARGET (2016)
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein
Shuai Gao et al.
CELL REPORTS (2016)
Regulatory Roles of MAPK Phosphatases in Cancer
Heng Boon Low et al.
IMMUNE NETWORK (2016)
Stromal Androgen Receptor Roles in the Development of Normal Prostate, Benign Prostate Hyperplasia, and Prostate Cancer
Simeng Wen et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Prostate Specific Antigen. Current clinical application and future prospects
Katerina Duskova et al.
BIOMEDICAL PAPERS-OLOMOUC (2015)
Growth and migration of LNCaP prostate cancer cells are promoted by triclosan and benzophenone-1 via an androgen receptor signaling pathway
Seung-Hee Kim et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2015)
Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitor
Yuichiro Kanno et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2015)
Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells
Julia Lindqvist et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer
Y. Kim et al.
ONCOGENE (2015)
Stromal Androgen Receptor in Prostate Development and Cancer
Mandeep Singh et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Cyclin A2, a novel regulator of EMT
Nawal Bendris et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Androgen Receptor Promotes the Oncogenic Function of Overexpressed Jagged1 in Prostate Cancer by Enhancing Cyclin B1 Expression via Akt Phosphorylation
Yongjiang Yu et al.
MOLECULAR CANCER RESEARCH (2014)
Anti-neoplastic properties of hydralazine in prostate cancer
Ines Graca et al.
ONCOTARGET (2014)
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Yixuan Gong et al.
CANCERS (2014)
Increased Akt Signaling Resulting from the Loss of Androgen Responsiveness in Prostate Cancer
J. Dulinska-Litewka et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Interaction with Cyclin H/Cyclin-dependent Kinase 7 (CCNH/CDK7) Stabilizes C-terminal Binding Protein 2 (CtBP2) and Promotes Cancer Cell Migration
Yuchan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Role of Androgen Receptor in Progression of LNCaP Prostate Cancer Cells from G1 to S Phase
Shalini Murthy et al.
PLOS ONE (2013)
A novel function for Cyclin A2: Control of cell invasion via RhoA signaling
Nikola Arsic et al.
JOURNAL OF CELL BIOLOGY (2012)
Regulation of a Novel Androgen Receptor Target Gene, the Cyclin B1 Gene, through Androgen-Dependent E2F Family Member Switching
Yirong Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells
Anna Hsu et al.
CLINICAL EPIGENETICS (2011)
Cyclin H expression is increased in GIST with very-high risk of malignancy
Julian Dorn et al.
BMC CANCER (2010)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Restoration of cyclin D2 has an inhibitory potential on the proliferation of LNCaP cells
Takashi Kobayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prostate Cancer
Clay E. S. Comstock et al.
CLINICAL CANCER RESEARCH (2009)
Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma
Prashant Bavi et al.
HUMAN PATHOLOGY (2008)
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis
Barbara Wegiel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer
Yi Peng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression
Aijing Sun et al.
PROSTATE (2008)
Cyclin D3 action in androgen receptor regulation and prostate cancer
N. A. Olshavsky et al.
ONCOGENE (2008)
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
Barbara Wegiel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor
Hongliang Zong et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model
Tatyana Isayeva et al.
CANCER RESEARCH (2007)
Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones
Yanping Guo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2007)
Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy
Lourdes A. Gomez et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy
Subbareddy Maddika et al.
DRUG RESISTANCE UPDATES (2007)
Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer
Rui Henrique et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes
June X. Zou et al.
PROSTATE (2006)
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu et al.
CANCER RESEARCH (2006)
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
CJ Burd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters
F Kayaselcuk et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
The cyclin D1b splice variant: an old oncogene learns new tricks
Karen E. Knudsen
CELL DIVISION (2006)
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis
SJ Libertini et al.
PROSTATE (2006)
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer
B Wegiel et al.
ONCOGENE (2005)
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression
CJ Burd et al.
MOLECULAR ENDOCRINOLOGY (2005)
Differential expression of cell cycle regulatory molecules and evidence for a cyclin switch during progression of prostate cancer
LA Maddison et al.
PROSTATE (2004)
Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth
K Minamiguchi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Distinct functions of condensin I and II in mitotic chromosome assembly
T Hirota et al.
JOURNAL OF CELL SCIENCE (2004)
Molecular communication between androgen receptor and general transcription machinery
DK Lee et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
D Karan et al.
CARCINOGENESIS (2002)
Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor
HK Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer
MA Dall'Era et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2001)
Cyclin E as a coactivator of the androgen receptor
A Yamamoto et al.
JOURNAL OF CELL BIOLOGY (2000)
Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression
JR Graff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents
LJ Rasmussen et al.
EXPERIMENTAL CELL RESEARCH (2000)
From androgen receptor to the general transcription factor TFIIH -: Identification of cdk activating kinase (CAK) as an androgen receptor NH2-terminal associated coactivator
DK Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
